<table id="ID153" width="95%" xmlns="urn:hl7-org:v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<caption>Table 15. Summary of Drug Interactions With Lamotrigine </caption>
<col width="33%"></col>
<col width="32%"></col>
<col width="30%"></col>
<tfoot>
<tr>
<td align="left" colspan="3">
<paragraph>*  From adjunctive clinical trials and volunteer studies.<br/>
</paragraph>
<paragraph>
<sup>†</sup> Net effects were estimated by comparing the mean clearance values obtained in adjunctive clinical trials and volunteers studies. <br/>
</paragraph>
<paragraph>
<sup>‡</sup>  The effect of other hormonal contraceptive preparations or hormone replacement therapy on the    pharmacokinetics of lamotrigine has not been systematically evaluated in clinical trials, although the effect may be similar to that seen with the ethinylestradiol/levonorgestrel combinations.<br/>
</paragraph>
<paragraph>
<sup>§</sup>  Modest decrease in levonorgestrel <br/>
</paragraph>
<paragraph>
<sup>|</sup>
<sup> |</sup>   Not administered, but an active metabolite of carbamazepine.<br/>
</paragraph>
<paragraph>
<sup>¶</sup> Slight decrease, not expected to be clinically relevant.<br/>
</paragraph>
<paragraph>
<sup>#</sup>  Not administered, but an active metabolite of oxcarbazepine. <br/>
</paragraph>
<paragraph>** Slight increase not expected to be clinically relevant. <br/>
</paragraph>
<paragraph>↔ = No significant effect.<br/>
</paragraph>
<paragraph>? = Conflicting data.<br/>
</paragraph>
</td>
</tr>
</tfoot>
<tbody>
<tr>
<td align="center" stylecode=" Lrule Rrule Botrule Toprule" valign="bottom">Drug<br/>
</td>
<td align="center" stylecode=" Lrule Rrule Botrule Toprule" valign="bottom">Drug PlasmaConcentration With<br/>Adjunctive<br/>Lamotrigine*<br/>
</td>
<td align="center" stylecode=" Lrule Rrule Botrule Toprule" valign="bottom">Lamotrigine Plasma<br/>Concentration With <br/>Adjunctive Drugs<sup>†</sup>
<br/>
</td>
</tr>
<tr>
<td align="left" stylecode=" Lrule Rrule Botrule Toprule" valign="top">Oral contraceptives (e.g., <br/>ethinylestradiol/levonorgestrel)<sup>‡</sup>
<br/>Bupropion <br/>Carbamazepine (CBZ) <br/>CBZ epoxide<sup>|</sup>
<sup>|</sup>
<br/>Felbamate <br/>Gabapentin <br/>Levetiracetam <br/>Lithium <br/>Olanzapine <br/>Oxcarbazepine <br/>10-monohydroxy oxcarbazepine <br/>   metabolite<sup>#</sup> <br/>Phenobarbital/primidone <br/>Phenytoin (PHT) <br/>Pregabalin <br/>Rifampin <br/>Topiramate <br/>Valproate <br/>Valproate <content stylecode="italics">+ </content>PHT and/or CBZ <br/>Zonisamide<br/>
</td>
<td align="center" stylecode=" Lrule Rrule Botrule Toprule" valign="top">↔§<br/>
<br/>Not assessed<br/>↔<br/>?<br/>Not assessed<br/>Not assessed<br/>↔<br/>↔<br/>↔<br/>↔<br/>↔<br/>
<br/>↔<br/>↔<br/>↔<br/>Not assessed<br/>↔**<content stylecode="italics">
<br/>
</content>↓<br/>Not assessed<br/>Not assessed<br/>
</td>
<td align="center" stylecode=" Lrule Rrule Botrule Toprule" valign="top">↓<br/>
<br/>↔<br/>↓<br/>
<br/>↔<br/>↔<br/>↔<br/>Not assessed<br/>↔<sup>¶</sup>
<br/>↔<br/>
<br/>
<br/>↓<br/>↓<br/>↔<br/>↓<br/>↔<br/>↑<br/>↔<br/>↔<br/>
</td>
</tr>
</tbody>
</table>